nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Niacin—atherosclerosis	0.0684	0.169	CbGbCtD
Fingolimod—CYP2D6—Simvastatin—atherosclerosis	0.0541	0.134	CbGbCtD
Fingolimod—CYP2D6—Lovastatin—atherosclerosis	0.0529	0.131	CbGbCtD
Fingolimod—CYP2D6—Pravastatin—atherosclerosis	0.0529	0.131	CbGbCtD
Fingolimod—CYP3A4—Ezetimibe—atherosclerosis	0.037	0.0916	CbGbCtD
Fingolimod—CYP3A4—Rosuvastatin—atherosclerosis	0.037	0.0916	CbGbCtD
Fingolimod—CYP3A4—Simvastatin—atherosclerosis	0.0344	0.0851	CbGbCtD
Fingolimod—CYP3A4—Lovastatin—atherosclerosis	0.0336	0.0833	CbGbCtD
Fingolimod—CYP3A4—Pravastatin—atherosclerosis	0.0336	0.0833	CbGbCtD
Fingolimod—S1PR1—umbilical vein—atherosclerosis	0.0285	0.222	CbGeAlD
Fingolimod—S1PR1—endothelium—atherosclerosis	0.0135	0.105	CbGeAlD
Fingolimod—S1PR1—blood vessel—atherosclerosis	0.0125	0.0972	CbGeAlD
Fingolimod—Macular oedema—Niacin—atherosclerosis	0.00922	0.0645	CcSEcCtD
Fingolimod—S1PR4—adipose tissue—atherosclerosis	0.00797	0.0621	CbGeAlD
Fingolimod—S1PR1—connective tissue—atherosclerosis	0.0064	0.0498	CbGeAlD
Fingolimod—S1PR3—cardiovascular system—atherosclerosis	0.00631	0.0492	CbGeAlD
Fingolimod—S1PR3—adipose tissue—atherosclerosis	0.00557	0.0434	CbGeAlD
Fingolimod—S1PR1—cardiovascular system—atherosclerosis	0.00557	0.0434	CbGeAlD
Fingolimod—SPHK1—cardiovascular system—atherosclerosis	0.00551	0.0429	CbGeAlD
Fingolimod—S1PR1—adipose tissue—atherosclerosis	0.00491	0.0382	CbGeAlD
Fingolimod—SPHK1—adipose tissue—atherosclerosis	0.00486	0.0378	CbGeAlD
Fingolimod—S1PR5—liver—atherosclerosis	0.0047	0.0366	CbGeAlD
Fingolimod—CYP4F12—adipose tissue—atherosclerosis	0.00466	0.0363	CbGeAlD
Fingolimod—CYP4F2—liver—atherosclerosis	0.0044	0.0343	CbGeAlD
Fingolimod—S1PR3—liver—atherosclerosis	0.0039	0.0304	CbGeAlD
Fingolimod—S1PR1—liver—atherosclerosis	0.00344	0.0268	CbGeAlD
Fingolimod—CYP4F12—liver—atherosclerosis	0.00327	0.0255	CbGeAlD
Fingolimod—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00327	0.0229	CcSEcCtD
Fingolimod—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00312	0.0219	CcSEcCtD
Fingolimod—Herpes zoster—Niacin—atherosclerosis	0.00299	0.0209	CcSEcCtD
Fingolimod—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00269	0.0189	CcSEcCtD
Fingolimod—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00253	0.0177	CcSEcCtD
Fingolimod—Eczema—Simvastatin—atherosclerosis	0.00198	0.0139	CcSEcCtD
Fingolimod—Influenza—Rosuvastatin—atherosclerosis	0.00194	0.0136	CcSEcCtD
Fingolimod—Bronchitis—Rosuvastatin—atherosclerosis	0.00187	0.0131	CcSEcCtD
Fingolimod—Eczema—Niacin—atherosclerosis	0.00182	0.0127	CcSEcCtD
Fingolimod—Depression—Rosuvastatin—atherosclerosis	0.00172	0.0121	CcSEcCtD
Fingolimod—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00172	0.0121	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00168	0.0118	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00165	0.0115	CcSEcCtD
Fingolimod—Influenza—Lovastatin—atherosclerosis	0.00164	0.0115	CcSEcCtD
Fingolimod—Sinusitis—Rosuvastatin—atherosclerosis	0.00162	0.0114	CcSEcCtD
Fingolimod—Influenza—Ezetimibe—atherosclerosis	0.00161	0.0113	CcSEcCtD
Fingolimod—Migraine—Niacin—atherosclerosis	0.00161	0.0113	CcSEcCtD
Fingolimod—Liver function test abnormal—Niacin—atherosclerosis	0.00151	0.0106	CcSEcCtD
Fingolimod—Liver function test abnormal—Pravastatin—atherosclerosis	0.00149	0.0104	CcSEcCtD
Fingolimod—Bronchitis—Simvastatin—atherosclerosis	0.00148	0.0104	CcSEcCtD
Fingolimod—Infestation—Ezetimibe—atherosclerosis	0.00144	0.0101	CcSEcCtD
Fingolimod—Infestation NOS—Ezetimibe—atherosclerosis	0.00144	0.0101	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00142	0.00993	CcSEcCtD
Fingolimod—Influenza—Niacin—atherosclerosis	0.00141	0.00988	CcSEcCtD
Fingolimod—Influenza—Pravastatin—atherosclerosis	0.00139	0.00973	CcSEcCtD
Fingolimod—Sinusitis—Lovastatin—atherosclerosis	0.00138	0.00962	CcSEcCtD
Fingolimod—Depression—Simvastatin—atherosclerosis	0.00137	0.00957	CcSEcCtD
Fingolimod—Mental disorder—Rosuvastatin—atherosclerosis	0.00136	0.00952	CcSEcCtD
Fingolimod—Bronchitis—Niacin—atherosclerosis	0.00136	0.0095	CcSEcCtD
Fingolimod—Sinusitis—Ezetimibe—atherosclerosis	0.00135	0.00944	CcSEcCtD
Fingolimod—Sinusitis—Simvastatin—atherosclerosis	0.00129	0.009	CcSEcCtD
Fingolimod—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00127	0.00888	CcSEcCtD
Fingolimod—Weight decreased—Pravastatin—atherosclerosis	0.00126	0.0088	CcSEcCtD
Fingolimod—Depression—Pravastatin—atherosclerosis	0.00124	0.00865	CcSEcCtD
Fingolimod—Cough—Rosuvastatin—atherosclerosis	0.00118	0.00826	CcSEcCtD
Fingolimod—Angiopathy—Ezetimibe—atherosclerosis	0.00117	0.0082	CcSEcCtD
Fingolimod—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00116	0.00814	CcSEcCtD
Fingolimod—Sinusitis—Pravastatin—atherosclerosis	0.00116	0.00814	CcSEcCtD
Fingolimod—Alopecia—Lovastatin—atherosclerosis	0.00116	0.00814	CcSEcCtD
Fingolimod—Alopecia—Ezetimibe—atherosclerosis	0.00114	0.00798	CcSEcCtD
Fingolimod—Mental disorder—Ezetimibe—atherosclerosis	0.00113	0.00791	CcSEcCtD
Fingolimod—Back pain—Lovastatin—atherosclerosis	0.00111	0.00775	CcSEcCtD
Fingolimod—Infection—Rosuvastatin—atherosclerosis	0.0011	0.00767	CcSEcCtD
Fingolimod—Alopecia—Simvastatin—atherosclerosis	0.00109	0.00761	CcSEcCtD
Fingolimod—Back pain—Ezetimibe—atherosclerosis	0.00109	0.00761	CcSEcCtD
Fingolimod—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00108	0.00757	CcSEcCtD
Fingolimod—Vision blurred—Lovastatin—atherosclerosis	0.00108	0.00756	CcSEcCtD
Fingolimod—Mental disorder—Simvastatin—atherosclerosis	0.00108	0.00755	CcSEcCtD
Fingolimod—Eye disorder—Niacin—atherosclerosis	0.00106	0.00739	CcSEcCtD
Fingolimod—Cardiac disorder—Pravastatin—atherosclerosis	0.00103	0.00723	CcSEcCtD
Fingolimod—Angiopathy—Niacin—atherosclerosis	0.00103	0.00718	CcSEcCtD
Fingolimod—Leukopenia—Lovastatin—atherosclerosis	0.00103	0.00718	CcSEcCtD
Fingolimod—Vision blurred—Simvastatin—atherosclerosis	0.00101	0.00707	CcSEcCtD
Fingolimod—Alopecia—Niacin—atherosclerosis	0.000999	0.00699	CcSEcCtD
Fingolimod—Palpitations—Ezetimibe—atherosclerosis	0.000993	0.00695	CcSEcCtD
Fingolimod—Paraesthesia—Rosuvastatin—atherosclerosis	0.000991	0.00693	CcSEcCtD
Fingolimod—Alopecia—Pravastatin—atherosclerosis	0.000983	0.00688	CcSEcCtD
Fingolimod—Cough—Ezetimibe—atherosclerosis	0.00098	0.00686	CcSEcCtD
Fingolimod—Hypertension—Ezetimibe—atherosclerosis	0.00097	0.00679	CcSEcCtD
Fingolimod—Leukopenia—Simvastatin—atherosclerosis	0.000959	0.00671	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00095	0.00665	CcSEcCtD
Fingolimod—Infection—Lovastatin—atherosclerosis	0.000929	0.0065	CcSEcCtD
Fingolimod—Vision blurred—Niacin—atherosclerosis	0.000927	0.00649	CcSEcCtD
Fingolimod—Vision blurred—Pravastatin—atherosclerosis	0.000913	0.00639	CcSEcCtD
Fingolimod—Infection—Ezetimibe—atherosclerosis	0.000911	0.00638	CcSEcCtD
Fingolimod—Nervous system disorder—Ezetimibe—atherosclerosis	0.000899	0.00629	CcSEcCtD
Fingolimod—CYP2E1—cardiovascular system—atherosclerosis	0.000892	0.00695	CbGeAlD
Fingolimod—Skin disorder—Ezetimibe—atherosclerosis	0.000891	0.00623	CcSEcCtD
Fingolimod—Leukopenia—Niacin—atherosclerosis	0.000881	0.00616	CcSEcCtD
Fingolimod—Palpitations—Niacin—atherosclerosis	0.000869	0.00608	CcSEcCtD
Fingolimod—Infection—Simvastatin—atherosclerosis	0.000869	0.00608	CcSEcCtD
Fingolimod—Leukopenia—Pravastatin—atherosclerosis	0.000867	0.00607	CcSEcCtD
Fingolimod—Cough—Niacin—atherosclerosis	0.000859	0.00601	CcSEcCtD
Fingolimod—Cough—Pravastatin—atherosclerosis	0.000845	0.00592	CcSEcCtD
Fingolimod—Paraesthesia—Lovastatin—atherosclerosis	0.000839	0.00588	CcSEcCtD
Fingolimod—Hypertension—Pravastatin—atherosclerosis	0.000836	0.00585	CcSEcCtD
Fingolimod—Dyspnoea—Lovastatin—atherosclerosis	0.000834	0.00583	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000832	0.00582	CcSEcCtD
Fingolimod—Paraesthesia—Ezetimibe—atherosclerosis	0.000823	0.00576	CcSEcCtD
Fingolimod—Dyspnoea—Ezetimibe—atherosclerosis	0.000818	0.00572	CcSEcCtD
Fingolimod—Fatigue—Lovastatin—atherosclerosis	0.000806	0.00564	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000792	0.00554	CcSEcCtD
Fingolimod—Asthenia—Rosuvastatin—atherosclerosis	0.000792	0.00554	CcSEcCtD
Fingolimod—Fatigue—Ezetimibe—atherosclerosis	0.000791	0.00553	CcSEcCtD
Fingolimod—Infection—Pravastatin—atherosclerosis	0.000785	0.0055	CcSEcCtD
Fingolimod—Paraesthesia—Simvastatin—atherosclerosis	0.000785	0.0055	CcSEcCtD
Fingolimod—Pruritus—Rosuvastatin—atherosclerosis	0.00078	0.00546	CcSEcCtD
Fingolimod—Skin disorder—Niacin—atherosclerosis	0.00078	0.00546	CcSEcCtD
Fingolimod—Dyspnoea—Simvastatin—atherosclerosis	0.00078	0.00546	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000755	0.00528	CcSEcCtD
Fingolimod—Diarrhoea—Rosuvastatin—atherosclerosis	0.000755	0.00528	CcSEcCtD
Fingolimod—Fatigue—Simvastatin—atherosclerosis	0.000754	0.00528	CcSEcCtD
Fingolimod—Hypotension—Niacin—atherosclerosis	0.00075	0.00525	CcSEcCtD
Fingolimod—Dizziness—Rosuvastatin—atherosclerosis	0.00073	0.00511	CcSEcCtD
Fingolimod—Paraesthesia—Niacin—atherosclerosis	0.000721	0.00505	CcSEcCtD
Fingolimod—Dyspnoea—Niacin—atherosclerosis	0.000716	0.00501	CcSEcCtD
Fingolimod—Paraesthesia—Pravastatin—atherosclerosis	0.00071	0.00497	CcSEcCtD
Fingolimod—Dyspnoea—Pravastatin—atherosclerosis	0.000705	0.00493	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Niacin—atherosclerosis	0.000693	0.00485	CcSEcCtD
Fingolimod—Headache—Rosuvastatin—atherosclerosis	0.000691	0.00484	CcSEcCtD
Fingolimod—Fatigue—Pravastatin—atherosclerosis	0.000682	0.00477	CcSEcCtD
Fingolimod—Asthenia—Lovastatin—atherosclerosis	0.000671	0.00469	CcSEcCtD
Fingolimod—Pruritus—Lovastatin—atherosclerosis	0.000661	0.00463	CcSEcCtD
Fingolimod—Asthenia—Ezetimibe—atherosclerosis	0.000658	0.0046	CcSEcCtD
Fingolimod—Pruritus—Ezetimibe—atherosclerosis	0.000649	0.00454	CcSEcCtD
Fingolimod—Diarrhoea—Lovastatin—atherosclerosis	0.00064	0.00448	CcSEcCtD
Fingolimod—Asthenia—Simvastatin—atherosclerosis	0.000627	0.00439	CcSEcCtD
Fingolimod—Diarrhoea—Ezetimibe—atherosclerosis	0.000627	0.00439	CcSEcCtD
Fingolimod—Pruritus—Simvastatin—atherosclerosis	0.000619	0.00433	CcSEcCtD
Fingolimod—Dizziness—Lovastatin—atherosclerosis	0.000618	0.00433	CcSEcCtD
Fingolimod—Dizziness—Ezetimibe—atherosclerosis	0.000606	0.00424	CcSEcCtD
Fingolimod—Diarrhoea—Simvastatin—atherosclerosis	0.000598	0.00419	CcSEcCtD
Fingolimod—Headache—Lovastatin—atherosclerosis	0.000586	0.0041	CcSEcCtD
Fingolimod—Dizziness—Simvastatin—atherosclerosis	0.000578	0.00405	CcSEcCtD
Fingolimod—Asthenia—Niacin—atherosclerosis	0.000576	0.00403	CcSEcCtD
Fingolimod—Headache—Ezetimibe—atherosclerosis	0.000574	0.00402	CcSEcCtD
Fingolimod—Pruritus—Niacin—atherosclerosis	0.000568	0.00398	CcSEcCtD
Fingolimod—Asthenia—Pravastatin—atherosclerosis	0.000567	0.00397	CcSEcCtD
Fingolimod—Pruritus—Pravastatin—atherosclerosis	0.000559	0.00391	CcSEcCtD
Fingolimod—CYP2E1—liver—atherosclerosis	0.000552	0.0043	CbGeAlD
Fingolimod—Diarrhoea—Niacin—atherosclerosis	0.000549	0.00384	CcSEcCtD
Fingolimod—Headache—Simvastatin—atherosclerosis	0.000548	0.00383	CcSEcCtD
Fingolimod—Diarrhoea—Pravastatin—atherosclerosis	0.000541	0.00379	CcSEcCtD
Fingolimod—Dizziness—Niacin—atherosclerosis	0.000531	0.00372	CcSEcCtD
Fingolimod—Dizziness—Pravastatin—atherosclerosis	0.000523	0.00366	CcSEcCtD
Fingolimod—Headache—Niacin—atherosclerosis	0.000503	0.00352	CcSEcCtD
Fingolimod—Headache—Pravastatin—atherosclerosis	0.000495	0.00347	CcSEcCtD
Fingolimod—CYP3A4—liver—atherosclerosis	0.000444	0.00346	CbGeAlD
Fingolimod—CYP2D6—liver—atherosclerosis	0.000437	0.0034	CbGeAlD
Fingolimod—S1PR5—Signaling Pathways—INS—atherosclerosis	4.99e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—INS—atherosclerosis	4.99e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL2—atherosclerosis	4.91e-05	0.000151	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL2—atherosclerosis	4.91e-05	0.000151	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PDGFB—atherosclerosis	4.91e-05	0.000151	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NOS3—atherosclerosis	4.9e-05	0.000151	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—atherosclerosis	4.89e-05	0.000151	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1—atherosclerosis	4.83e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1—atherosclerosis	4.83e-05	0.000149	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—INS—atherosclerosis	4.8e-05	0.000148	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AGT—atherosclerosis	4.79e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CG—atherosclerosis	4.79e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SERPINE1—atherosclerosis	4.76e-05	0.000147	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOE—atherosclerosis	4.69e-05	0.000144	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—LEP—atherosclerosis	4.69e-05	0.000144	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CAV1—atherosclerosis	4.65e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	4.65e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LDLRAP1—atherosclerosis	4.64e-05	0.000143	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOA1—atherosclerosis	4.64e-05	0.000143	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—MAPK3—atherosclerosis	4.59e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	4.58e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SERPINE1—atherosclerosis	4.58e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SERPINE1—atherosclerosis	4.58e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOS3—atherosclerosis	4.55e-05	0.00014	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—INS—atherosclerosis	4.53e-05	0.000139	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ESR1—atherosclerosis	4.48e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—atherosclerosis	4.48e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL2—atherosclerosis	4.46e-05	0.000137	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—F2—atherosclerosis	4.43e-05	0.000136	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ALB—atherosclerosis	4.4e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1—atherosclerosis	4.38e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOS3—atherosclerosis	4.38e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOS3—atherosclerosis	4.38e-05	0.000135	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLTP—atherosclerosis	4.37e-05	0.000134	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CG—atherosclerosis	4.24e-05	0.00013	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NOS3—atherosclerosis	4.21e-05	0.000129	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SERPINE1—atherosclerosis	4.16e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—atherosclerosis	4.03e-05	0.000124	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—INS—atherosclerosis	4.01e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOS3—atherosclerosis	3.97e-05	0.000122	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL2—atherosclerosis	3.95e-05	0.000121	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—atherosclerosis	3.9e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—atherosclerosis	3.88e-05	0.000119	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—atherosclerosis	3.88e-05	0.000119	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1—atherosclerosis	3.88e-05	0.000119	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—atherosclerosis	3.85e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—atherosclerosis	3.84e-05	0.000118	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LTA4H—atherosclerosis	3.79e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCG8—atherosclerosis	3.79e-05	0.000117	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—atherosclerosis	3.75e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—atherosclerosis	3.75e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—atherosclerosis	3.69e-05	0.000114	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—atherosclerosis	3.69e-05	0.000114	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SERPINE1—atherosclerosis	3.68e-05	0.000113	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—atherosclerosis	3.65e-05	0.000112	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKB1—atherosclerosis	3.61e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK8—atherosclerosis	3.55e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—atherosclerosis	3.54e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—atherosclerosis	3.53e-05	0.000108	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOS3—atherosclerosis	3.52e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—atherosclerosis	3.51e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—atherosclerosis	3.51e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKB1—atherosclerosis	3.47e-05	0.000107	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKB1—atherosclerosis	3.47e-05	0.000107	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK8—atherosclerosis	3.42e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK8—atherosclerosis	3.42e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—atherosclerosis	3.41e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—atherosclerosis	3.41e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—atherosclerosis	3.41e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—atherosclerosis	3.35e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	3.3e-05	0.000101	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—atherosclerosis	3.28e-05	0.000101	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—atherosclerosis	3.24e-05	9.98e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—atherosclerosis	3.19e-05	9.81e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKB1—atherosclerosis	3.15e-05	9.71e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—atherosclerosis	3.15e-05	9.7e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—atherosclerosis	3.15e-05	9.7e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—atherosclerosis	3.12e-05	9.61e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—atherosclerosis	3.12e-05	9.61e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—atherosclerosis	3.12e-05	9.6e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK8—atherosclerosis	3.1e-05	9.54e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLTP—atherosclerosis	3.1e-05	9.54e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—atherosclerosis	3.1e-05	9.54e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—atherosclerosis	3.09e-05	9.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.04e-05	9.35e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—atherosclerosis	3.01e-05	9.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3e-05	9.22e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCG1—atherosclerosis	2.99e-05	9.21e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—atherosclerosis	2.98e-05	9.18e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—atherosclerosis	2.98e-05	9.18e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—atherosclerosis	2.89e-05	8.91e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—atherosclerosis	2.89e-05	8.91e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—atherosclerosis	2.86e-05	8.81e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—atherosclerosis	2.84e-05	8.72e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—atherosclerosis	2.82e-05	8.68e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LCAT—atherosclerosis	2.81e-05	8.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FABP4—atherosclerosis	2.81e-05	8.66e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKB1—atherosclerosis	2.79e-05	8.59e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA4—atherosclerosis	2.76e-05	8.5e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK8—atherosclerosis	2.74e-05	8.45e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP7A1—atherosclerosis	2.71e-05	8.35e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—atherosclerosis	2.71e-05	8.34e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LTA4H—atherosclerosis	2.69e-05	8.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG8—atherosclerosis	2.69e-05	8.27e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—atherosclerosis	2.63e-05	8.09e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—atherosclerosis	2.61e-05	8.02e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—atherosclerosis	2.53e-05	7.8e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—atherosclerosis	2.51e-05	7.72e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP27A1—atherosclerosis	2.51e-05	7.72e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—atherosclerosis	2.4e-05	7.38e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	2.38e-05	7.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA2—atherosclerosis	2.38e-05	7.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALOX15—atherosclerosis	2.38e-05	7.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	2.38e-05	7.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCG5—atherosclerosis	2.35e-05	7.23e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—atherosclerosis	2.33e-05	7.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LPA—atherosclerosis	2.27e-05	6.98e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—atherosclerosis	2.27e-05	6.97e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—atherosclerosis	2.25e-05	6.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BGN—atherosclerosis	2.2e-05	6.76e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—atherosclerosis	2.18e-05	6.71e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—atherosclerosis	2.18e-05	6.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA5—atherosclerosis	2.17e-05	6.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.15e-05	6.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.12e-05	6.54e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	2.09e-05	6.44e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—atherosclerosis	2.09e-05	6.43e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLTP—atherosclerosis	2.03e-05	6.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALOX5—atherosclerosis	2.02e-05	6.22e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—atherosclerosis	2.01e-05	6.19e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—atherosclerosis	2.01e-05	6.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LCAT—atherosclerosis	2e-05	6.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FABP4—atherosclerosis	2e-05	6.15e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—atherosclerosis	1.98e-05	6.09e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA4—atherosclerosis	1.96e-05	6.03e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—atherosclerosis	1.93e-05	5.95e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.93e-05	5.93e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—atherosclerosis	1.83e-05	5.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.81e-05	5.58e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LIPC—atherosclerosis	1.8e-05	5.55e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOC3—atherosclerosis	1.79e-05	5.51e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LDLR—atherosclerosis	1.78e-05	5.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.78e-05	5.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.76e-05	5.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.76e-05	5.41e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—atherosclerosis	1.75e-05	5.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CETP—atherosclerosis	1.74e-05	5.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.69e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.69e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.69e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA2—atherosclerosis	1.69e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.67e-05	5.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.66e-05	5.12e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—atherosclerosis	1.62e-05	4.98e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LPA—atherosclerosis	1.61e-05	4.95e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.57e-05	4.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BGN—atherosclerosis	1.56e-05	4.8e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA5—atherosclerosis	1.54e-05	4.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.49e-05	4.57e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.43e-05	4.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.4e-05	4.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.39e-05	4.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FABP4—atherosclerosis	1.31e-05	4.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LCAT—atherosclerosis	1.31e-05	4.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.29e-05	3.96e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA4—atherosclerosis	1.28e-05	3.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LIPC—atherosclerosis	1.28e-05	3.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOC3—atherosclerosis	1.27e-05	3.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LDLR—atherosclerosis	1.26e-05	3.89e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.26e-05	3.87e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CETP—atherosclerosis	1.23e-05	3.8e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.2e-05	3.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.18e-05	3.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.16e-05	3.58e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOB—atherosclerosis	1.15e-05	3.54e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.12e-05	3.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.12e-05	3.43e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.1e-05	3.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.1e-05	3.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA2—atherosclerosis	1.1e-05	3.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.1e-05	3.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LPL—atherosclerosis	1.1e-05	3.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.09e-05	3.35e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—atherosclerosis	1.07e-05	3.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LPA—atherosclerosis	1.05e-05	3.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD36—atherosclerosis	1.04e-05	3.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BGN—atherosclerosis	1.02e-05	3.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA5—atherosclerosis	1.01e-05	3.11e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.94e-06	3.06e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—atherosclerosis	9.9e-06	3.05e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARA—atherosclerosis	9.71e-06	2.99e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.71e-06	2.99e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AGT—atherosclerosis	9.41e-06	2.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.38e-06	2.89e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—atherosclerosis	9.22e-06	2.84e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—atherosclerosis	9.13e-06	2.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA1—atherosclerosis	9.11e-06	2.8e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.53e-06	2.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.41e-06	2.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LIPC—atherosclerosis	8.36e-06	2.57e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—atherosclerosis	8.32e-06	2.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOC3—atherosclerosis	8.31e-06	2.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LDLR—atherosclerosis	8.26e-06	2.54e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOB—atherosclerosis	8.17e-06	2.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CETP—atherosclerosis	8.07e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—atherosclerosis	8.03e-06	2.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.95e-06	2.45e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—INS—atherosclerosis	7.87e-06	2.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LPL—atherosclerosis	7.8e-06	2.4e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.72e-06	2.38e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—atherosclerosis	7.61e-06	2.34e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD36—atherosclerosis	7.41e-06	2.28e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.29e-06	2.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—atherosclerosis	7.22e-06	2.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.03e-06	2.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—atherosclerosis	6.91e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARA—atherosclerosis	6.89e-06	2.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AGT—atherosclerosis	6.68e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—atherosclerosis	6.54e-06	2.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.5e-06	2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—atherosclerosis	6.48e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA1—atherosclerosis	6.47e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—atherosclerosis	6.32e-06	1.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.9e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—atherosclerosis	5.7e-06	1.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—INS—atherosclerosis	5.59e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.58e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOB—atherosclerosis	5.34e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.2e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—atherosclerosis	5.12e-06	1.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LPL—atherosclerosis	5.1e-06	1.57e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—atherosclerosis	4.98e-06	1.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—atherosclerosis	4.9e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD36—atherosclerosis	4.85e-06	1.49e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.59e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARA—atherosclerosis	4.51e-06	1.39e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.48e-06	1.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AGT—atherosclerosis	4.36e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—atherosclerosis	4.28e-06	1.32e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—atherosclerosis	4.24e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA1—atherosclerosis	4.23e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.86e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—atherosclerosis	3.72e-06	1.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—INS—atherosclerosis	3.65e-06	1.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—atherosclerosis	3.35e-06	1.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—atherosclerosis	3.2e-06	9.86e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—atherosclerosis	3.17e-06	9.77e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.93e-06	9.02e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—atherosclerosis	2.25e-06	6.93e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—atherosclerosis	1.47e-06	4.53e-06	CbGpPWpGaD
